Podcast Atlas
concept Updated 2026-08-21 Topics: Technology, Science

AI For Science

Anthropic’s Generational Run, OpenAI Panics, AI Moats, Meta Loses Lawsuits adds a PCAST-adjacent policy view. Friedberg frames AI as changing what is possible in science, while the council’s remit over biotech, semiconductors, quantum, nuclear, and China competition links AI-for-science to public advisory institutions rather than only labs or startups.

Bill Maris: How Google Could Crush AI Competitors, Why Small Funds Win, and AI’s Atari Stage adds Bill Maris’s life-sciences version through Calico, Section 32, and Computational Biology. Maris argues that computation could matter enormously if realistic simulation of a human cell becomes possible, but the episode keeps AI-for-biology bounded by titration, safety, clinical testing, FDA processes, basic-research funding, and scientific talent flows.

Inside America’s AI Strategy: Infrastructure, Regulation, and Global Competition adds the U.S. government scientific-data version through Michael Kratsios and the Genesis Mission. The source says useful scientific data is fragmented across chemistry, math, materials science, and other formats, while Department of Energy national labs hold decades of research that could support model training, simulation, and discovery.

EP 8: Implementation of AI in scientific research adds a biomedical computational-biology version through Lucas Simon at Baylor College of Medicine’s Therapeutic Innovation Center. The source makes the representation and infrastructure layer explicit: Bioinformatics, sequencing pipelines, gene expression matrices, Molecular Feature Engineering, Single-Cell RNA Sequencing, and Biomedical Deep Learning determine when deep learning can reveal biologically meaningful cell structure.

Data, AI, and Scientific Research: A Coffee Chat adds an experimental-practice version through Data Science With Sam, Effie, and Mossam. The source treats AI for Science less as a frontier-lab breakthrough story and more as a lab-data quality problem: Experimental Science Data Quality, Bioinformatics Domain Gap, Negative Results As Scientific Data, Retrosynthesis AI, Radiochemistry Imaging Tracers, Blood-Brain Barrier Prediction, and Human-Driven Scientific AI determine whether AI suggestions can become usable scientific work.

EP 6: Data Science & AI Talk adds the neuroscience-training branch through Paulina Nemkova’s EEG Brain Reading work. The source connects AI-for-science ambition to Academic AI Research Role, AI Research Literature Currency, Research Replication Integrity, and Locked-In Syndrome Assistive Communication, while keeping the technical claim narrow: EEG classification can infer object categories, not complete thoughts or consciousness.

EP 4: A.I. talk with a Rocket Scientist from NASA adds a NASA space-research version through Kofi Browning. It keeps the same grounded posture but shifts the constraint from wet-lab documentation to Spaceflight AI Dataset Scarcity: many mission events are too rare for large-data machine learning, while Space Imagery AI and EVA Glove Inspection AI are more credible because visual review produces bounded, inspectable tasks.

178: 与田渊栋聊 RSI：模型自进化如何到来？ adds 田渊栋’s staged route from AI-for-AI to broader science. He argues that Recursive Superintelligence should first prove itself on AI research because feedback is faster and more measurable; if the system can find useful architectures, theories, or optimization methods there, it may later extend into other scientific discovery domains.

AI for Science is one of the episode’s proposed ways to avoid direct competition with foundation-model bulldozers. The host lists areas such as chip design, material discovery, mining, mathematics, and quantum-computer design as examples of higher-complexity work with deeper industry know-how.

149. 亲历中美 New Labs 资本狂潮，和清华刘子鸣聊：AI for AI、机制可解释性和 Max Tegmark adds Liu Ziming’s distinction between AI for Science and Physics Of AI. He began with AI for Physics but later reversed the direction: scientific and physics-style methods became tools for understanding AI itself. The same episode also treats AI for Science as one of the hottest New Lab financing themes alongside World Models and AI For AI.

EP266 当AI重构大学，我们该如何定义“好专业”？ adds the higher-education and talent-pipeline version through AI For Science Talent / AI for Science人才. 李小杰 argues that basic science may become more important, not less, when AI enters discovery: chemistry, physics, mathematics, theory, computation, and experimental understanding are the foundation that lets students use AI in semiconductors, batteries, pharma, materials, and research institutes.

哪条路线，才能通往「世界模型」的终局？｜对话黄碧薇：Aether AI 创始人 adds Huang Biwei’s causal view: scientific domains such as biopharma, new materials, astronomy, and physical-world discovery are less forgiving than language and code because they require deeper causal understanding under changing conditions.

“你有一把能够挖出金子的铲子，肯定不会先给别人用”｜对谈开物纪陆子恒：用AI发明新材料 adds the concrete materials version through Lu Ziheng and Kaiwuji. It turns AI for Science into AI Materials Discovery: AI-generated candidates still have to pass synthesizability, property, experiment, kilogram-scale, customer, and commercialization tests before they count as useful scientific progress.

How convergence will define the tech sector in 2026 adds a public forecasting bridge from AI for science to Programmable Matter and Generative Biology. Amy Webb connects materials with new energy, medicine, building, and packaging possibilities, then links biology and chemistry to generative workflows where data can produce candidate molecules or genomes.

145. 口述SpaceX开发史：和前高管洪力德聊，马斯克用人观、最大IPO、太空与AI、人类文明扩张前奏？ adds an aerospace version through SpaceX. Louis Hong / 洪力德 argues that AI can help space work through simulation, material science, system design, and physical-world modeling, while space may help AI through Space Based AI Infrastructure. This extends AI for Science from lab discovery into the infrastructure and engineering systems needed to test and deploy physical technologies.

E242｜最快半年AI跑通自进化？与陈天桥首席科学家聊聊硅谷模型必争之地 adds Apodex’s Heavy Duty Solver version. The source treats AI for Science as part of a broader Discovery Model ambition: models should not only retrieve existing knowledge, but generate hard hypotheses, write code or run simulations, and verify whether the result is real. Its first named application areas include biology, medicine, drug discovery, old-drug repurposing, and diagnosis, but the episode’s core constraint is general: AI Verification and Research Taste determine whether discovery claims are useful.

137. 对洪乐潼的4小时访谈：AI for Math、把数学变成Lean、数学天书中的证明、直觉、被创造与被发现的 adds Hong Letong / 洪乐潼’s AI For Math bridge. She treats mathematics as a digital sandbox for reliable reasoning because feedback can be formal and fast through Lean Theorem Prover and Interactive Theorem Proving, while many physical sciences require labs, experiments, and slower real-world feedback. In that view, Mathematical Abundance can later support science and engineering by supplying more verified theory.

AI4S 需要狂人与野心家｜对话英灵殿 Odin："如果神存在，我怎能容忍自己不是神？"【公路播客】 adds the life-science startup version through Haotian Odin / 浩天 and Yinglingdian AI / 英灵殿. The source makes All-Modal Molecular World Model the technical bet: small molecules, proteins, RNA, and DNA should be modeled together because biological intervention crosses molecular modalities. It also adds AI Drug Discovery Platform, AI Protein Design, Scientific Discovery Automation, and Platform-Pipeline Biotech Strategy, making AI for Science a combined model, experiment, team, customer, and financing problem.

E226｜聊聊DeepMind创始人哈萨比斯：一个科学家与失控的AI竞赛 adds the founder-history version through Demis Hassabis. The 硅谷101 episode treats AlphaFold as the clearest realization of Hassabis’s claim that AI should help humanity solve hard scientific problems, while Scientific Ideal vs AI Arms Race keeps that optimism tied to competition and governance risk.

vol.117.生物医药的2025：抄底中国、研发焦虑和新王继位 adds the industry-skeptical AI drug version. 小P老师 still lists AI drug as a 2025 direction, but AI Clinical Validation In Drug Discovery makes clinical readouts the deciding evidence rather than platform narrative, demo quality, or model architecture.

「热爱一个行业15年的理由是什么？」｜对谈汪天凡：我要投真正的快乐、投最纯的愿景、投人性的光辉【公路播客】 adds Will Wang Tianfan / 汪天凡’s founder-vision boundary. He argues that in AI for science, AI may be only the tool layer; the decisive question is whether the founder has a large enough scientific or human vision to use the tool toward a meaningful starting point.

Investment Logic

  • Scientific and industrial domains may be harder to commoditize than lightweight software wrappers.
  • They require specialized knowledge, data, and operational credibility.
  • They sit near other moonshot themes such as Embodied AI and World Models.
  • Causal AI and Causal World Models may matter because scientific systems often require reasoning about interventions, hidden variables, and state transitions.
  • AI Materials Discovery suggests that AI-for-science startups may need to own long validation and commercialization loops, not just provide models or APIs.
  • Discovery Model work adds a second moat question: can the system choose valuable scientific questions and verify answers, not only generate candidates?
  • AI For Math may be an unusually clean AI-for-science route because formal proof gives better verification signals than most empirical domains.
  • All-Modal Molecular World Model adds a biological route where verification must pass molecular interaction, synthesis, wet-lab, and customer-use constraints.
  • AI Clinical Validation In Drug Discovery adds the stricter drug-development version: human clinical data can reprice AI-for-biology claims faster than platform language can defend them.
  • Episode 149 adds a bidirectional boundary: AI can help science, but science-like structure may also be needed to make AI For AI credible.
  • Wang Tianfan’s source adds that founder vision and starting motivation matter especially when AI is a tool applied to a deeper scientific problem.
  • Tian’s source adds an ordering claim: AI research itself may be the first science-like domain for self-improving systems because experiments, benchmarks, and training results can return faster than wet-lab or physical-world feedback.
  • The Data Science With Sam source adds a lower-level lab constraint: reliable records, failed experiments, domain translation, and safety oversight are prerequisites for using AI in biology, chemistry, and radiochemistry.
  • EP8 adds a molecular-data constraint: deep learning becomes credible only after raw-read processing, feature representation, matrix construction, data scale, and biological interpretation are strong enough.
  • Data Science With Sam EP6 adds that AI-for-neuroscience claims need literature currency, replication, and careful capability boundaries before assistive or medical applications should be inferred.
  • The NASA episode adds that scientific AI also depends on event frequency and data shape: imagery-heavy space tasks can work earlier than one-off mission-event prediction.
  • The All-In source adds a public-data and national-lab route: scientific AI may accelerate faster when government-held experimental and simulation records become usable training and verification assets.
  • The Maris All-In source adds a venture and biology route: computation may accelerate life sciences, but the bottleneck stays in real human biology, clinical evidence, regulation, and scientific institution quality.

Connections